Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-J Luboldt

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Urologia Internationalis|December 11, 1999
Prognostic factors for carcinoma of the prostateJ E Altwein, H J Luboldt
Der Urologe. Ausg. A|March 19, 1999
[Secondary erectile dysfunction. Is oral medication in the diagnostic phase indicated?]H Sperling, G Lümmen, H J Luboldt, et al.
Der Urologe. Ausg. A|April 15, 2008
[Early detection of prostate cancer in Germany. A study of a representative random sample of the population]M Sieverding, U Matterne, L Ciccarello, et al.
Der Urologe. Ausg. A|May 1, 1995
[Cytokine therapy of metastatic renal cell carcinoma]T Otto, M Goepel, H J Luboldt, et al.
Onkologie|March 29, 2003
[German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma]H Rübben, K Schalkhäuser, J Wolff, et al.
Der Urologe. Ausg. A|August 21, 2009
[Free/total PSA ratio in clinical and ambulatory application. Are different cutoffs justified?]A Swoboda, H-J Luboldt, H Rübben, et al.
Cancer Research|February 15, 1996
Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinomaH J Luboldt, B S Kubens, H Rübben, et al.
Lancet (London, England)|January 11, 1997
Hepatoblastoma in a 2-year-old child of a liver-transplanted motherC Roll, H J Luboldt, A Winter, et al.
Der Urologe. Ausg. A|May 14, 2011
[Parameters to improve the specificity of the prostate-specific antigen. Early detection of prostate cancer]C Börgermann, S Kliner, A Swoboda, et al.
European Urology|February 27, 2001
Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoffH J Luboldt, A Bex, A Swoboda, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Urologia Internationalis|December 11, 1999
Prognostic factors for carcinoma of the prostateJ E Altwein, H J Luboldt
Der Urologe. Ausg. A|March 19, 1999
[Secondary erectile dysfunction. Is oral medication in the diagnostic phase indicated?]H Sperling, G Lümmen, H J Luboldt, et al.
Der Urologe. Ausg. A|April 15, 2008
[Early detection of prostate cancer in Germany. A study of a representative random sample of the population]M Sieverding, U Matterne, L Ciccarello, et al.
Der Urologe. Ausg. A|May 1, 1995
[Cytokine therapy of metastatic renal cell carcinoma]T Otto, M Goepel, H J Luboldt, et al.
Onkologie|March 29, 2003
[German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma]H Rübben, K Schalkhäuser, J Wolff, et al.
Der Urologe. Ausg. A|August 21, 2009
[Free/total PSA ratio in clinical and ambulatory application. Are different cutoffs justified?]A Swoboda, H-J Luboldt, H Rübben, et al.
Cancer Research|February 15, 1996
Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinomaH J Luboldt, B S Kubens, H Rübben, et al.
Lancet (London, England)|January 11, 1997
Hepatoblastoma in a 2-year-old child of a liver-transplanted motherC Roll, H J Luboldt, A Winter, et al.
Der Urologe. Ausg. A|May 14, 2011
[Parameters to improve the specificity of the prostate-specific antigen. Early detection of prostate cancer]C Börgermann, S Kliner, A Swoboda, et al.
European Urology|February 27, 2001
Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoffH J Luboldt, A Bex, A Swoboda, et al.
Pageof 2